Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02286856
Other study ID # NL39724.091.1
Secondary ID
Status Completed
Phase N/A
First received October 31, 2014
Last updated April 13, 2017
Start date March 2014
Est. completion date March 2017

Study information

Verified date April 2016
Source Radboud University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The m.3243A>G mutation is the most frequent cause of mitochondrial disease in adults, for which currently no therapy is available and treatment is solely supportive. Since both malnutrition and obesity are frequently seen in these patients, an adequate nutritional intervention to improve body composition and function might improve the quality of life of these patients.

Hypothesis / research questions Hypothesis part 1: Patients with mitochondrial disorders caused by the m.3243 A>G mutation have an increased risk for malnutrition.

Hypothesis part 2 : Intervention study: Dietary intervention in adults with a mitochondrial disorder caused by the m.3243 A>G mutation has a positive effect on nutritional status, activity, hand grip strength, body composition, food intake, fatigue and quality of life.


Description:

Background

The Nijmegen Centre for Metabolic Disease (NCMD) harbors a unique research center with much experience in the characterization of the group of patients with the m3243A>G mutation.

For a mitochondrial disease no therapy is available. Treatment is supportive, and aims at improving the quality of life. Clinical findings in patients with mitochondrial diseases may both comprise malnutrition and obesity. While a nutritional intervention might constitute a symptomatic treatment for these patients, there are very few data in adults to guide such a strategy.

Malnutrition is defined as a state of nutrition in which a deficiency, excess (or imbalance) of energy, protein, and other nutrients causes measurable adverse effects on body composition and function, and clinical outcome. In patients with mitochondrial disease there is by definition malnutrition on a cellular level due to disturbed metabolism with energy deficit. A logical next step is to study the effect of this energy shortage on complaints in the adult population by describing characteristics of this patient group in relation to the nutritional status. In the same vein, a controlled dietary intervention might result in an evidence based dietary therapy.

Frequent symptoms of patients with OXPHOS disorders include e gastrointestinal problems, fatigue and dysphagia. We suspect that these symptoms increase the risk for malnutrition. Research in patients with neuromuscular disorders have demonstrated that none of the patients had an adequate nutritional state, with a a lowered Fat Free Mass and a high fat percentage.

Study design:

Part 1 comprises a comprehensive Nutritional Assessment (NA) including indirect calorimetry (IC), bioimpedance analysis (BIA), anthropometry, eating report, activity measurement using the actometer, and completion of questionnaires including the Cis-fatigue and SF-36 for Quality of life.

In Part 2 a 2-armed randomized controlled intervention study is performed . One group starts with a dietary intervention whereas the second group (controls) starts with a non-interventional period of 6 months. After this period the dietary intervention is also performed in the second group . The dietary intervention implies optimizing the diet based on individually calculated energy and protein requirements, while for remaining nutrients advise in line with recommended daily amounts (RDA) will be provided. Extended Nutritional Assessment measurements will be repeated every 3 months. Indirect Calorimetry will be performed at the start of the study.

Objective of the study:

1. To increase our knowledge about the nutritional status of adult patients with mitochondrial disease and its determinants.

2. Evaluate effects of a dietary intervention in these patients on nutritional status and body functions (muscle strength, activity, fatigue) and quality of life.

3. To develop criteria to refer patients with mitochondrial disease for dietary intervention.

DINAMITE study acronym DIner: Hot meal, super NA: Nutritional Assessment or Nutrition + Adults MIT MITochondrial disorder E Energy


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Proven mitochondrial m.3243A>G mutation

- Age > 18 years

- No medical contra indication for receiving Nutritional Assessment after overnight fasting

- Informed consent

Exclusion Criteria:

- Overnight fasting is contraindicated for medical reasons, for example due to high risk for hypoglycemia.

- Pacemaker

- Claustrophobia

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
diet intervention
The dietary intervention implies optimizing the diet based on individually calculated energy and protein requirements, while for remaining nutrients advise in line with recommended daily amounts (RDA) will be provided. This nutrients will be translated to food products and lifestyle advice is added. Individual diet counseling will be part of the intervention to improve compliance.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Radboud University

Outcome

Type Measure Description Time frame Safety issue
Primary Nutritional Status Patient Generated- Subjective Global Assessment (Pg-SGA) 3- 6 months
Secondary Activity measured with sensewear in Kcal 3-6 months
Secondary body composition measured with bioimpedance analysis (FFMI) 3- 6 months
Secondary waist circumference (cm) 3- 6 months
Secondary upper arm circumference (cm) 3- 6 months
Secondary antropometric BMI 3- 6 months
Secondary food intake measured by 3 day eating report 3- 6 months
Secondary occurrence of gastrointestinal problems questionaire 3- 6 months
Secondary hand grip strength Kg 3- 6 months
Secondary fatigue measured with the CIS (Checklist Individual tension) fatigue 3- 6 months
Secondary quality of life Short Form (SF)-36 3- 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT06080581 - Mitochondrial Dysfunctions Driving Insulin Resistance
Completed NCT01137240 - Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders N/A
Recruiting NCT06213103 - Mitochondrial Disease-associated ImmunoDeficiencies
Completed NCT00406445 - Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome
Enrolling by invitation NCT01803906 - Tissue Sample Study for Mitochondrial Disorders
Recruiting NCT01780168 - The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism
Recruiting NCT01694940 - North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Recruiting NCT06080594 - Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance N/A
Completed NCT02804828 - Mitochondrial Cocktail for Gulf War Illness N/A